...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Probiotics Can Further Reduce Waist Circumference in Adults with Morbid Obesity after Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
【24h】

Probiotics Can Further Reduce Waist Circumference in Adults with Morbid Obesity after Bariatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

机译:益生菌可以进一步减少大肥胖手术后病态肥胖的成人腰围:随机对照试验的系统评价和荟萃分析

获取原文
           

摘要

Whether probiotics could be used as an adjunct to bariatric surgery is controversial. This meta-analysis aimed to evaluate the effects of probiotics on body weight, body mass index (BMI), percentage of the excess weight loss (%EWL), waist circumference (WC), and C-reactive protein (CRP) in adults with obesity after bariatric surgery (BS). PUBMED, EMBASE, and the Cochrane Central Registry of Controlled Trials were searched from the earliest record to March 2020. All randomized controlled trials (RCTs) on the effects of probiotics in adults with obesity after bariatric surgery were analyzed according to the eligibility criteria. Four RCTs, including 172 participants, were analyzed. There was a statistically significant difference in probiotics in the reduction of waist circumference at 12 months after bariatric surgery. However, probiotics were not effective in weight, BMI, %EWL, WC, and CRP both within 3 months and at 12 months postoperation. Probiotics aid adults with morbid obesity in achieving further waist circumference improvement after BS, with no significant effect on weight, BMI, %EWL, and CRP. More quality clinical studies are needed to confirm the efficacy and safety of probiotics, and address a number of practical issues before the routine clinical use of probiotics in adults with obesity undergoing BS.
机译:益生菌是否可以用作牛肝外科的辅助方法是有争议的。该荟萃分析旨在评估益生菌对体重,体重指数(BMI),过量减肥(%EWL),腰围(%EWL),腰围(WC)和C-反应性蛋白(CRP)的百分比的作用肥胖手术后肥胖症(BS)。从最早的纪录到3月20日期,对受控试验的PubMed,Embase和Cochrane Central Registry进行了搜查。根据资格标准,分析了所有随机对照试验(RCT)对肥胖症后肥胖症患者肥胖症患者的影响。分析了四个RCT,包括172名参与者。肥胖手术后12个月在腰围减少的益生菌存在统计学上显着差异。然而,在术后12个月和12个月内,益生菌在重量,BMI,%EWL,WC和CRP中无效。益生菌辅助成人具有病态肥胖在BS后实现进一步的腰围改善,对重量,BMI,%EWL和CRP没有显着影响。需要更高质量的临床研究来确认益生菌的疗效和安全性,并在益生菌患者中患有肥胖症的益生菌的常规临床应用前解决了许多实际问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号